Content and data provided by various third parties and Fidelity − Terms of Use

Stock Details

RELATED RESOURCES
Print Format
Change Text Size:

BRIEF-SQZ Biotechnologies Presents New EAPC Preclinical Data

BY Reuters
— 7:38 AM ET 04/11/2022

April 11 (Reuters) - SQZ Biotechnologies Co (SQZ):

* SQZ BIOTECHNOLOGIES PRESENTS NEW EAPC PRECLINICAL DATA DEMONSTRATING THAT MULTIPLEXED MRNA ENGINEERING OF IMMUNE CELLS INCREASES KILLER T CELL ACTIVITY IN VIVO Source text for Eikon: Further company coverage:

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

More SQZ News
Copyright 1998–2022 FMR LLC. 
All rights reserved. 
Close